Genmab — Juni 2017

[Raffles]

Regarding the presentations I believe we should also mention JnJ participate in Jefferies 2017 conference on june 8th. Trust DARA will be mentioned:-)

[jkj]

3 onsdag i hver mrd.

[E_L]

Sure, these banks will invite their customers. But the bigger ones will deal with all these banks anyway

[E_L]

thks Raffles

[Nickstar]

Tak JKJ

[Joakim_Von_And]

Hvad hedder næste gap der skal lukkes??

[Solsen]

ha - vi er i sell on facts mode og kan komme godt ned, tror jeg.

[Solsen]

Who cares

[Joakim_Von_And]

1350??

[Solsen]

Måske

[kkjoel]

@Nickstar: Salgstallene fra Syphony Health kommer 2. onsdag efter 2. lørdag hver måned.
Mærkeligt regel, men sådan er det.

[Legolas23]

Det kunne også være et sell-out for at presse private invetstorer ud inden godkendelse i 3. linie og salgstal. For mig ligner det et spekulativt salg af de anonyme for at køre andre private over
.

[BobTheThird]

Helt enig Legolas. Ville heller ikke være overrasket hvis den vender endnu engang ved udangen af i dag.

[Nickstar]

Ah, så forstår jeg.
tak Kkjoel

[Helge_LarsenPI-redaktør]

Sydbank på Play: https://play.borsen.dk/social/5934ee2c45628ff817205648

[kkjoel]

Danske Bank: "6 June 2017 / Investment cases and follow-ups / Genmab (Buy) / Daratumumab has been presented at ASCO with encouraging cytogenetic risk data and solid DKRd NDMM data; but inconclusive vs historical KRd ORR rates. The POLLUX PFS continues its strong trend to support long-term maintenance use. We keep our Buy rating and DKK1,670 per share 12-month target price."

[E_L]

Well, they only just raised it back up there 2 weeks ago, i guess we can forgive them

[kkjoel]

Forgive them, father - for they have sinned

[gentogen]

A Pilot Presurgical Study of Daratumumab in Men With High-Risk Localized Prostate Cancer

[gentogen]

https://clinicaltrials.gov/ct2/show/NCT03177460?term=daratumumab&rcv_s=05%2F20%2F2017&rcv_e=06%2F06%2F2017&rank=1